167 related articles for article (PubMed ID: 9618418)
1. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
Smith GD; Smith MT
J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
[TBL] [Abstract][Full Text] [Related]
2. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
3. Biochemical synthesis, purification and preliminary pharmacological evaluation of normorphine-3-glucuronide.
Smith GD; Prankerd RJ; Smith MT
Life Sci; 1997; 61(2):95-104. PubMed ID: 9217268
[TBL] [Abstract][Full Text] [Related]
4. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration.
Hemstapat K; Le L; Edwards SR; Smith MT
Pharmacol Biochem Behav; 2009 Oct; 93(4):498-505. PubMed ID: 19580825
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
[TBL] [Abstract][Full Text] [Related]
7. Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance.
South SM; Wright AW; Lau M; Mather LE; Smith MT
J Pharmacol Exp Ther; 2001 Apr; 297(1):446-57. PubMed ID: 11259573
[TBL] [Abstract][Full Text] [Related]
8. Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.
Gardmark M; Karlsson MO; Jonsson F; Hammarlund-Udenaes M
J Pharm Sci; 1998 Jul; 87(7):813-20. PubMed ID: 9649348
[TBL] [Abstract][Full Text] [Related]
9. Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-Dawley rats: differences between the tail flick and hot plate nociceptive tests.
South SM; Edwards SR; Smith MT
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):20-8. PubMed ID: 18671713
[TBL] [Abstract][Full Text] [Related]
10. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive tolerance to morphine from repeated nociceptive testing in the rat.
Lane DA; Morgan MM
Brain Res; 2005 Jun; 1047(1):65-71. PubMed ID: 15878767
[TBL] [Abstract][Full Text] [Related]
12. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.
Smith GD; Smith MT
Pain; 1995 Jul; 62(1):51-60. PubMed ID: 7478708
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine.
Smith DJ; Hawranko AA; Monroe PJ; Gully D; Urban MO; Craig CR; Smith JP; Smith DL
J Pharmacol Exp Ther; 1997 Aug; 282(2):899-908. PubMed ID: 9262357
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
16. Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.
Wright AW; Mather LE; Smith MT
Life Sci; 2001 Jun; 69(4):409-20. PubMed ID: 11459432
[TBL] [Abstract][Full Text] [Related]
17. Plastic changes of calcitonin gene-related peptide in morphine tolerance: behavioral and immunohistochemical study in rats.
Zhou X; Li JJ; Yu LC
J Neurosci Res; 2003 Nov; 74(4):622-9. PubMed ID: 14598307
[TBL] [Abstract][Full Text] [Related]
18. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat.
Nielsen CK; Ross FB; Smith MT
J Pharmacol Exp Ther; 2000 Oct; 295(1):91-9. PubMed ID: 10991965
[TBL] [Abstract][Full Text] [Related]
19. Disposition and analgesic effects of systemic morphine, morphine-6-glucuronide and normorphine in rat.
Hasselström J; Svensson JO; Säwe J; Wiesenfeld-Hallin Z; Yue QY; Xu XJ
Pharmacol Toxicol; 1996 Jul; 79(1):40-6. PubMed ID: 8841095
[TBL] [Abstract][Full Text] [Related]
20. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
